Roger J. Daly
23 Innovation Walk
Clayton, VIC 3800, Australia
Clayton, VIC 3800, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 106 publications
A tandem recruitment site in the pseudokinase scaffold PEAK3 is subject to phosphorylation-dependent regulation and cancer-associated mutations.
Journal: The Journal of biological chemistry
Published: August 03, 2025
Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young.
Journal: Molecular cancer therapeutics
Published: July 01, 2025
Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young.
Journal: Molecular cancer therapeutics
Published: July 01, 2025
Ion channel modulator DPI-201-106 significantly enhances antitumor activity of DNA damage response inhibitors in glioblastoma.
Journal: Neuro-oncology advances
Published: December 11, 2024
Non-redundant roles of the phosphoinositide phosphatases PTEN and PIPP in PI3K/AKT signaling in breast cancer.
Journal: Communications biology
Published: November 10, 2024
BMP4-Induced Suppression of Breast Cancer Metastasis Is Associated with Inhibition of Cholesterol Biosynthesis.
Journal: International journal of molecular sciences
Published: June 26, 2024
View from the PEAKs: Insights from structural studies on the PEAK family of pseudokinases.
Journal: Current opinion in structural biology
Published: April 28, 2024
Activation of CAMK2 by pseudokinase PEAK1 represents a targetable pathway in triple negative breast cancer.
Journal: Nature communications
Published: March 07, 2024
Feed-forward stimulation of CAMK2 by the oncogenic pseudokinase PEAK1 generates a therapeutically "actionable" signalling axis in triple negative breast cancer.
Journal: bioRxiv : the preprint server for biology
Published: February 26, 2024
Integrative Modeling of Signaling Network Dynamics Identifies Cell Type-Selective Therapeutic Strategies for FGFR4-Driven Cancers.
Journal: Cancer research
Published: November 02, 2023
Last Updated: 09/26/2026